drugset / Trial / NCT03925818

Low Dose Bismuth Versus Lactobacillus Reuteri for H. Pylori Eradication

NCT03925818

Terminated 99 enrolled Università degli Studi di Sassari
RandomizedParallel-groupOpen-labelTreatment

Summary

This study investigates the efficacy of a b.i.d. quadruple therapy containing Pylera® or L. reuteri for H. pylori infection.

Timeline

Start
2017-08-29
Primary completion
2018-11-29
Completion
2018-12-23

Drugs

EvaluationDrugModalityDoseRoute
Subject bismuth subcitrate Unknown 140 mg